[АNTISEPTICS: MODERN STRATEGY OF STRUGGLE WITH CAUSING AGENTS OF THE ІNFECTION COMPLICATIONS]

Klin Khir. 2016:(9):59-61.
[Article in Ukrainian]

Abstract

Etiology of infective complications was investigated in 71 injured persons, suffering severe burns. There was established, that the main causing agents in patients, suffering burn disease, are S. aureus(in 35.9% of observations), A. baumannii (in 25%), P. aeruginosa (in 12.82%), P. mirabilis (in 5.12%). Resistance of conditionally pathogenic microorganisms towards cephalosporins, аminoglycosides, іmipenem, meropenem, doxycycline was determined. Effective bactericidal activity of antiseptic solutions of decasan, miramistinum, chlorhexidine was proved. High antimicrobial properties of dressing materials, which contain decametoxine, chlorhexidine, furagin, silver ions against Staphylococcus were noted. Clinical efficacy of application of materials, impregnated by antimicrobial composition decametoxine with carboxymethylstarch, oxyethylcellulose and polyvynilacetate, for prophylaxis and treatment of infective purulent—inflammatory complications in patients, suffering burns, was proved.

MeSH terms

  • Adult
  • Aminoglycosides / therapeutic use
  • Anti-Bacterial Agents / therapeutic use*
  • Anti-Infective Agents, Local / therapeutic use*
  • Bandages
  • Burns / drug therapy*
  • Burns / microbiology
  • Burns / pathology
  • Carbapenems / therapeutic use
  • Cephalosporins / therapeutic use
  • Chlorhexidine / therapeutic use
  • Decamethonium Compounds / therapeutic use
  • Doxycycline / therapeutic use
  • Drug Combinations
  • Drug Synergism
  • Female
  • Humans
  • Male
  • Middle Aged
  • Proteus Infections / drug therapy*
  • Proteus Infections / microbiology
  • Proteus Infections / pathology
  • Proteus mirabilis / drug effects
  • Proteus mirabilis / growth & development
  • Pseudomonas Infections / drug therapy*
  • Pseudomonas Infections / microbiology
  • Pseudomonas Infections / pathology
  • Pseudomonas aeruginosa / drug effects
  • Pseudomonas aeruginosa / growth & development
  • Staphylococcal Infections / drug therapy*
  • Staphylococcal Infections / microbiology
  • Staphylococcal Infections / pathology
  • Staphylococcus aureus / drug effects
  • Staphylococcus aureus / growth & development
  • Wound Infection / drug therapy*
  • Wound Infection / microbiology
  • Wound Infection / pathology

Substances

  • Aminoglycosides
  • Anti-Bacterial Agents
  • Anti-Infective Agents, Local
  • Carbapenems
  • Cephalosporins
  • Decamethonium Compounds
  • Drug Combinations
  • decamethoxine
  • Doxycycline
  • Chlorhexidine